|
|
Estrogen
Replacement and Coronary-Artery Atherosclerosis
Observational studies suggest that postmenopausal estrogen-replacement therapy
reduces the risk of cardiovascular events, although the recent Heart and
Estrogen/Progestin Replacement Study has called this conclusion into question
with respect to women with known coronary artery disease. This current randomized
study found no effect of either estrogen alone or estrogen plus progestin
on the progression of established coronary lesions as assessed by quantitative
methods over 3.2 years of follow-up.
Trends
in the Incidence of Coronary Disease and Changes in Diet and Lifestyle
in Women
This study of nearly 86,000 nurses found that the incidence of coronary
heart disease declined by 31 percent between 1980 and 1994. Two thirds of
the decline could be explained by a reduction in smoking, improvements in
diet, and an increase in the use of postmenopausal hormone-replacement therapy.
An increase in obesity, however, slowed the trend.
Siblings,
Day Care, and the Risk of Asthma in Children
Among children followed from birth to 13 years of age, the incidence of
asthma and frequent wheezing episodes between the ages of 6 and 13 years
was lower among those who attended day care during the first 6 months of
life and those who had one or more older siblings at home than among those
without such exposure. A possible explanation for these findings is that
children with more exposure to other children may have more infections,
which in some way protect against asthma.
Hemoglobin
H Disease in Hong Kong
In
hemoglobin H disease, a common hemoglobinopathy in China and Southeast Asia,
two of the four a-globin genes are deleted and a third is deleted or mutated.
In this study, most patients in Hong Kong who had hemoglobin H disease had
deletions of three of the four a-globin genes. They had milder disease than
patients in whom the third a-globin gene was mutated. Iron overload, a frequent
and potentially serious complication of hemoglobin H disease, was independent
of the type of genetic abnormality. Hence, the types of abnormalities of
a-globin genes in hemoglobin H disease cannot account for all of its clinical
variations. |